Omniome Stock

omniome.comHealthcareFounded: 2013Funding to Date: $153.29MM

Omniome is a biotechnology company developing a proprietary DNA sequencing platform capable of delivering unsurpassed sequencing accuracy.

Register for Details

For more details on financing and valuation for Omniome, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Omniome.

Register Today

Team

Management Team

David Mullarkey
Chief Executive Officer, President & Board Member
Kelly Perez
Senior Vice President of Finance
Arnold Oliphant Ph.D
Chief Technology Officer
Ken Song MD
Executive Chairman
Melissa Tosca
Director, Finance and Accounting

Board Members

David Cruikshank
Kim Kamdar Ph.D
Dan Zabrowski Ph.D
Ken Song MD
Michael Yi
Boris Nikolic MD
Biomatics Capital
David Mullarkey

Other companies like Omniome in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$400.53MM
Sector
Last Round Est. Valuation
$298.33MM
Sector
Last Round Est. Valuation
$4.26B
Sector
 
 

News

Omniome, Inc., a San Diego, CA-based developer of an innovative DNA sequencing platform, raised an additional $60m and completed the Series C funding